Bioptik Technology Incorporation
4161
Rank in Stocks
#23903
Bioptik Technology Incorporation operates as a global entity, focusing on the... Bioptik Technology Incorporation operates as a global entity, focusing on the creation and distribution of medical instruments and diagnostic chemicals. The company's product line encompasses the EasyMate series of blood glucose monitoring systems, as well as comprehensive diagnostic devices designed to measure blood glucose, cholesterol, and uric acid levels, complete with their essential test strips. Beyond its healthcare offerings, Bioptik also provides a range of skincare solutions, including those formulated with hyaluronic acid, alongside various dietary supplements. Uniquely, the company diversifies its business by supplying biodiesel products. Founded in 1999, Bioptik Technology Incorporation is headquartered in Zhunan, Taiwan.
Share Price
$0.6310283
Last synced: 2026-11-10
Market Cap
$37.73M
Change (1 day)
0.24%
Change (1 year)
-25.07%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bioptik Technology Incorporation (4161)
Category
Healthcare
Operating Margin for Bioptik Technology Incorporation (4161)
Operating Margin as of November 2026 TTM: 7.77%
According to Bioptik Technology Incorporation's latest financial reports, its current operating margin (TTM) is 7.77%. At the end of 2025 the company had an operating margin of 7.97%.
Operating Margin history for Bioptik Technology Incorporation from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 7.77% | -2.51% |
| 2025 | 7.97% | -23.37% |
| 2024 | 10.40% | -4.50% |
| 2023 | 10.89% | 16.47% |
| 2022 | 9.35% | 154.08% |
| 2021 | 3.68% | -131.48% |
| 2020 | -11.69% | 4,396.15% |
| 2019 | -0.26% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -98.04% |
US
|
|
| 18.08% | -97.67% |
IE
|
|
| 21.25% | -97.27% |
US
|
|
| 21.05% | -97.29% |
US
|
|
| 28.09% | -96.38% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Bioptik Technology Incorporation's operating margin
What is Bioptik Technology Incorporation's operating margin?
Bioptik Technology Incorporation's operating margin is 7.77%, as of Nov 2026.
What was Bioptik Technology Incorporation's operating margin in 2025?
In 2025, Bioptik Technology Incorporation's operating margin was 7.97%, compared with 10.40% in 2024.
How has Bioptik Technology Incorporation's operating margin changed since 2020?
From 2020 to 2025, Bioptik Technology Incorporation's operating margin was highest in 2023 (10.89%) and lowest in 2020 (-11.69%).
How does Bioptik Technology Incorporation's operating margin compare with similar companies?
Bioptik Technology Incorporation's operating margin (7.77%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.